BSX vs CAMP · P/E 20, rev $16.75B vs rev $652.0K
Boston Scientific Corp (BSX) versus CAMP4 THERAPEUTICS CORPORATION (CAMP) — a side-by-side from cached financials, not a winner call.
Boston Scientific Corp (BSX) is a medical devices company listed on US.
CAMP4 THERAPEUTICS CORPORATION (CAMP) is a biotechnology company listed on NASDAQ.
Latest reported BSX revenue for 2024-12-31 was $16.75B. Net income was $1.85B. Revenue was up 17.6% from 2023-12-31 to 2024-12-31. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
Latest reported CAMP revenue for 2024-12-31 was $652.0K. Net income was -$51.8M. Revenue was up 86.3% from 2023-12-31 to 2024-12-31. CAMP currently screens at market cap $215.0M.
BSX currently screens at market cap $71.81B and trailing P/E 20.2. CAMP currently screens at market cap $215.0M.
Not investment advice. Open the BSX and CAMP stock pages for the full models.
Not investment advice.